Cargando…
Use of tocilizumab in COVID-19 pneumonia hospitalized patients. Cohort study
INTRODUCTION: In COVID 19, an aggressive inflammatory response called cytokine release storm has been described. It is mainly mediated by the activation of Interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α), mainly observed in critically ill patients. Among the multiple treatments proposed...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Asociación Colombiana de Medicina Crítica y Cuidado lntensivo. Published by Elsevier España, S.L.U.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671622/ http://dx.doi.org/10.1016/j.acci.2022.10.004 |